Signal #149892 · SEC 8-K

$ETON SEC Filing Alert & Real-Time AI Stock Impact Analysis

Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).

FAQ: $ETON filing catalyst

Why did $ETON trigger an AI stock catalyst alert?

$ETON triggered a Stock Catalyst AI alert on 2026-11-05 00:00:00 UTC for a SEC 8-K filing (AI Score: -4.0/10). Headline: Eton ET-700 Pilot Trial Shows Superior Tolerability but Significantly Weaker Efficacy vs GALZIN. Key points: - ET-700 reduced hepatic copper uptake by 12% vs 46% for GALZIN in baseline ratios (18% vs 58% in ITT, p=0.023). - Safety profile was superior with treatment-related adverse events in 1 of 12 ET-700 patients vs 8 of 12 for GALZIN. - Company is forced to evaluate new faster-release formulations in 2027 to address efficacy shortfall.

How did $ETON stock react after the SEC filing?

After the SEC 8-K for $ETON, observed market reaction: T0 price $47.15. Past moves do not guarantee future results.

Where can I get real-time $ETON SEC filing alerts?

Stock Catalyst AI pushes real-time SEC 8-K alerts for $ETON via Telegram and the VIP Web Terminal from €10/month.

$ETON

$ETON – Eton ET-700 Pilot Trial Shows Superior Tolerability but Significantly Weaker Efficacy vs GALZIN

Eton Pharmaceuticals, Inc.

2026-11-05 00:00:00 UTC · SEC 8-K · All $ETON

Unlocked archive · Analyzed in <2s at T0

Bearish AI Sentiment (-4.0 / 10)

ET-700 reduced hepatic copper uptake by 12% vs 46% for GALZIN in baseline ratios (18% vs 58% in ITT, p=0.023).
Safety profile was superior with treatment-related adverse events in 1 of 12 ET-700 patients vs 8 of 12 for GALZIN.
Company is forced to evaluate new faster-release formulations in 2027 to address efficacy shortfall.

Unlock Live VIP Terminal & Telegram – €10/mo Original filing →